These interactions make OICR-9429 a powerful inhibitor and an ideal chemical probe for further understanding of WDR5–MLL1 interaction and a potential therapeutic for MLL1-driven acute myeloid leukemias. The gene discussed is KMT2A; the disease is acute myeloid leukemia.